Indian peripheral neuropathy treatment Market Size, Share, Analysis, Industry Report and Forecast 2020-2026

Indian peripheral neuropathy treatment market is estimated to grow at a CAGR of 5.8% during the forecast period. The rising prevalence of diabetes is a major factor in accelerating market growth. As per the International Diabetes Federation (IDF), In India, the total cases of diabetes in adults were nearly 77 million in 2019. The most common diabetic complication is peripheral neuropathy. It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This condition affects the legs and feet first and is followed by hands and arms. This results in an increasing demand for diabetic peripheral neuropathy treatment in the country. Some antidepressants provide ease to nerve pain. Tricyclic antidepressants may support mild to moderate nerve pain. This class of drugs includes imipramine (Tofranil), amitriptyline, and desipramine (Norpramin).

To Request a Sample of our Report on Indian peripheral neuropathy treatment Market: https://www.omrglobal.com/request-sample/indian-peripheral-neuropathy-treatment-market

Indian peripheral neuropathy treatment market is segmented based on type and application. Based on type, the market is classified into antidepressants, pain relievers, antiseizure, and others. Based on the application, the market is classified into diabetes, chemotherapy-induced, and others. Rising cancer prevalence is leading to increasing demand for chemotherapy in the country. As per the World Health Organization (WHO), the number of new cancer incidences in India was nearly 1.1 million in 2018. This, in turn, is resulting in the demand for chemotherapy-induced peripheral neuropathy treatment in the country.

(Get 15% Discount on Buying this Report)

A full Report of Indian peripheral neuropathy treatment Market is Available at: https://www.omrglobal.com/industry-reports/indian-peripheral-neuropathy-treatment-market

Indian Peripheral Neuropathy Treatment Market Segmentation

By Type

· Antidepressants

· Pain Relievers

· Antiseizure

· Others

By Application

· Diabetes

· Chemotherapy-Induced

· Others

Company Profiles

· Alembic Pharmaceuticals Ltd.

· Product Analysis

· Recent Developments

· Alkem Laboratories Ltd.

· Cipla Ltd.

· Dr Reddy’s Laboratories Ltd.

· Eli Lilly and Co.

· Glenmark Pharmaceuticals Ltd.

· Laurus Labs Ltd.

· Lupin Ltd.

· Pfizer Inc.

· Teva Pharmaceutical Industries Ltd.

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.